Viewing Study NCT04131192


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2025-12-25 @ 1:52 PM
Study NCT ID: NCT04131192
Status: TERMINATED
Last Update Posted: 2022-05-06
First Post: 2019-10-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Sponsor: Sunshine Lake Pharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module